Skip to main content

Month: July 2023

Malaga Financial Corporation Reports Increased Earnings for the First Six Months of 2023

PALOS VERDES ESTATES, Calif., July 14, 2023 (GLOBE NEWSWIRE) — Malaga Financial Corporation “Company” (OTCPink:MLGF), the parent company of Malaga Bank FSB, today reported that net income for the six months ended June 30, 2023 was $11,469,000 ($1.34 basic and fully diluted earnings per share) compared to $9,774,000 ($1.14 basic and fully diluted earnings per share, as adjusted for the stock dividend declared on November 14, 2022) for the same period ended June 30, 2022, an increase of $1,695,000 or 17%. Net income for the quarter ended June 30, 2023 was $5,594,000 ($0.65 basic and fully diluted earnings per share), an increase of $615,000 or 12% from net income of $4,979,000 ($0.58 basic and fully diluted earnings per share, as adjusted for the stock dividend declared on November 14, 2022) for the quarter ended June 30, 2022, and...

Continue reading

Red White & Bloom and Aleafia Health Mutually Agree to Terminate Binding Letter Agreement

TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) and Aleafia Health Inc. (TSX: AH and OTCQB: ALEAF) (“Aleafia”) are announcing the mutual termination of the binding letter agreement entered into between the parties on June 6, 2023 (the “Letter Agreement”) in respect of the proposed business combination transaction (the “Proposed Transaction”), as detailed in the joint press release issued on June 7, 2023. The termination is without liability or cost to either party. Pursuant to the Letter Agreement, and as a pre-requisite to closing the previously announced Proposed Transaction, the approval of holders of Aleafia convertible debentures issued under the amended and restated debenture indenture providing for the issue of certain convertible debentures...

Continue reading

Apollo Tactical Income Fund Inc. Declares July 2023 Monthly Distribution of $0.122 Per Share

NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) — (NYSE: AIF) – Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of July 2023 of $0.122 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: July 21, 2023Record Date: July 24, 2023Payment Date: July 31, 2023Per Share Amount: $0.122 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Relations ManagerApollo Global Management, Inc.212-822-0625ebesen@apollo.com Forward-Looking StatementsThis press release may contain statements that are forward looking, as that term is defined by the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission in its rules, regulations and releases. These...

Continue reading

Apollo Senior Floating Rate Fund Inc. Declares July 2023 Monthly Distribution of $0.126 Per Share

NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) — (NYSE: AFT) – Apollo Senior Floating Rate Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of July 2023 of $0.126 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: July 21, 2023Record Date: July 24, 2023Payment Date: July 31, 2023Per Share Amount: $0.126 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Relations ManagerApollo Global Management, Inc.212-822-0625ebesen@apollo.com Forward-Looking StatementsThis press release may contain statements that are forward looking, as that term is defined by the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission in its rules, regulations and releases. These...

Continue reading

Reunion Neuroscience Inc. Obtains Final Court Order for Proposed Plan of Arrangement

TORONTO, July 14, 2023 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) (“Reunion” or the “Company“), a clinical-stage biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions is pleased to announce that, earlier today, the Ontario Superior Court of Justice (Commercial List) granted a final order approving the proposed arrangement (the “Arrangement“) under Section 192 of the Canada Business Corporations Act, with affiliates of MPM BioImpact (“MPM“). As previously announced, the Arrangement was approved by shareholders of the Company at its special meeting of shareholders held on July 12, 2023. Assuming that the remaining conditions precedent are satisfied or waived, Reunion anticipates...

Continue reading

Hingham Savings Reports Second Quarter 2023 Results

HINGHAM, Mass., July 14, 2023 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced results for the quarter ended June 30, 2023. Earnings Net income for the quarter ended June 30, 2023 was $8,248,000 or $3.84 per share basic and $3.76 per share diluted, as compared to $3,191,000 or $1.49 per share basic and $1.45 per share diluted for the same period last year. The Bank’s annualized return on average equity for the second quarter of 2023 was 8.27%, and the annualized return on average assets was 0.80%, as compared to 3.43% and 0.34% for the same period in 2022. Net income per share (diluted) for the second quarter of 2023 increased by 159% over the same period in 2022. Core net income for the quarter ended June 30, 2023, which represents net income excluding the after-tax gains and...

Continue reading

Emergia Inc. Announces the Debt Conversion into Shares

MONTREAL, July 14, 2023 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation or “Emergia”) is pleased to announce that in July 13, 2023 a lender has elected to convert some of their loans into shares of Emergia, totaling $100,000 at a price of $0.25 per share for a total of 400,000 shares being issued.  ABOUT EMERGIA INC. EMERGIA operates mainly in Canada in the development, acquisition, and management of multi-purpose real estate, including retail, multifamily, industrial, and office buildings as well as land for future development. The Corporation’s investment platform is based on an integrated, agile and efficient develop-to-own strategy that enables EMERGIA to benefit from development profits and the value-add while securing stable long-term returns. For more information, please visit www.emergia.com and www.sedar.com....

Continue reading

PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private Placement

TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it has entered into a definitive agreement for the purchase and sale of 166,666 of the Company’s ordinary shares (or pre-funded warrants in lieu thereof), at a purchase price of $9.00 per ordinary share, in a registered direct offering. In a concurrent private placement, the Company has agreed to issue in the offering unregistered warrants to purchase up to an aggregate of 166,666 ordinary shares. The offering is expected to close on or about July 18, 2023, subject to satisfaction of customary closing conditions. Maxim Group LLC is acting as the exclusive placement...

Continue reading

Nokia Corporation: Repurchase of own shares on 14.07.2023

Nokia CorporationStock Exchange Release14 July 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 14.07.2023 Espoo, Finland – On 14 July 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 396,497 3.56CEUX 503 3.52AQEU 0 0.00TQEX 0 0.00Total 397,000 3.56* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR),...

Continue reading

IMCD acquires O&3, an industry leading innovative natural ingredients supplier

main visual_IMCD acquires O&3, an industry leading innovative natural ingredients supplier Left to right (standing):•Piet van der Slikke, CEO, IMCD Group•Fenna van Zanten, Director M&A, IMCD Group•Richard Mell, Financial Director, IMCD UKLeft to right (sitting):•Jennifer Wood, Co-Founder, O&3•Paul Hanbury, Managing Director, IMCD UK•Thomas Kerfoot, Co-Founder, O&3•Eleanor Wade, Co-Founder, O&3ROTTERDAM, The Netherlands (14 July 2023) – IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, formulator of speciality chemicals and ingredients, and solutions provider today announces that IMCD UK has acquired 90% of the shares in O&3 Limited (“O&3”), an industry-leading supplier of speciality natural ingredients to the global beauty and personal care markets. Founded in 2018, harnessing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.